Schindler C - Search Results

1

Outcome of radioiodine therapy without, on or 3 days off carbimazole: a prospective interventional three-group comparison.

Walter MA, Christ-Crain M, Schindler C, Müller-Brand J, Müller B. Walter MA, et al. Among authors: schindler c. Eur J Nucl Med Mol Imaging. 2006 Jun;33(6):730-7. doi: 10.1007/s00259-006-0092-8. Epub 2006 Apr 11. Eur J Nucl Med Mol Imaging. 2006. PMID: 16607544 Clinical Trial.

2

Radioiodine therapy in hyperthyroidism: inverse correlation of pretherapeutic iodine uptake level and post-therapeutic outcome.

Walter MA, Christ-Crain M, Eckard B, Schindler C, Nitzsche EU, Müller-Brand J, Müller B. Walter MA, et al. Among authors: schindler c. Eur J Clin Invest. 2004 May;34(5):365-70. doi: 10.1111/j.1365-2362.2004.01349.x. Eur J Clin Invest. 2004. PMID: 15147334

3

Different strategies to overcome the effect of carbimazole on high- and low-dose radioiodine therapy: results from continuous dose-effect models.

Walter MA, Schindler C, Christ-Crain M, Müller-Brand J, Müller B. Walter MA, et al. Among authors: schindler c. Eur J Clin Invest. 2009 Jan;39(1):51-7. doi: 10.1111/j.1365-2362.2008.02061.x. Eur J Clin Invest. 2009. PMID: 19087129

4

Somatostatin-based radiopeptide therapy with [177Lu-DOTA]-TOC versus [90Y-DOTA]-TOC in neuroendocrine tumours.

Romer A, Seiler D, Marincek N, Brunner P, Koller MT, Ng QK, Maecke HR, Müller-Brand J, Rochlitz C, Briel M, Schindler C, Walter MA. Romer A, et al. Among authors: schindler c. Eur J Nucl Med Mol Imaging. 2014 Feb;41(2):214-22. doi: 10.1007/s00259-013-2559-8. Epub 2013 Oct 2. Eur J Nucl Med Mol Imaging. 2014. PMID: 24085501 Free article. Clinical Trial.

5

The value of [18F]FDG-PET in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease.

Walter MA, Melzer RA, Schindler C, Müller-Brand J, Tyndall A, Nitzsche EU. Walter MA, et al. Among authors: schindler c. Eur J Nucl Med Mol Imaging. 2005 Jun;32(6):674-81. doi: 10.1007/s00259-004-1757-9. Epub 2005 Mar 4. Eur J Nucl Med Mol Imaging. 2005. PMID: 15747154 Clinical Trial.

6

The dental safety profile of high-dose radioiodine therapy for thyroid cancer: long-term results of a longitudinal cohort study.

Walter MA, Turtschi CP, Schindler C, Minnig P, Müller-Brand J, Müller B. Walter MA, et al. Among authors: schindler c. J Nucl Med. 2007 Oct;48(10):1620-5. doi: 10.2967/jnumed.107.042192. Epub 2007 Sep 14. J Nucl Med. 2007. PMID: 17873131 Free article. Clinical Trial.

7

Response, survival, and long-term toxicity after therapy with the radiolabeled somatostatin analogue [90Y-DOTA]-TOC in metastasized neuroendocrine cancers.

Imhof A, Brunner P, Marincek N, Briel M, Schindler C, Rasch H, Mäcke HR, Rochlitz C, Müller-Brand J, Walter MA. Imhof A, et al. Among authors: schindler c. J Clin Oncol. 2011 Jun 10;29(17):2416-23. doi: 10.1200/JCO.2010.33.7873. Epub 2011 May 9. J Clin Oncol. 2011. PMID: 21555692 Clinical Trial.

8

Cohort study of somatostatin-based radiopeptide therapy with [(90)Y-DOTA]-TOC versus [(90)Y-DOTA]-TOC plus [(177)Lu-DOTA]-TOC in neuroendocrine cancers.

Villard L, Romer A, Marincek N, Brunner P, Koller MT, Schindler C, Ng QK, Mäcke HR, Müller-Brand J, Rochlitz C, Briel M, Walter MA. Villard L, et al. Among authors: schindler c. J Clin Oncol. 2012 Apr 1;30(10):1100-6. doi: 10.1200/JCO.2011.37.2151. Epub 2012 Mar 5. J Clin Oncol. 2012. PMID: 22393097

9

Response to [90Yttrium-DOTA]-TOC treatment is associated with long-term survival benefit in metastasized medullary thyroid cancer: a phase II clinical trial.

Iten F, Müller B, Schindler C, Rochlitz C, Oertli D, Mäcke HR, Müller-Brand J, Walter MA. Iten F, et al. Among authors: schindler c. Clin Cancer Res. 2007 Nov 15;13(22 Pt 1):6696-702. doi: 10.1158/1078-0432.CCR-07-0935. Clin Cancer Res. 2007. PMID: 18006770 Clinical Trial.

10

[(90)Yttrium-DOTA]-TOC response is associated with survival benefit in iodine-refractory thyroid cancer: long-term results of a phase 2 clinical trial.

Iten F, Muller B, Schindler C, Rasch H, Rochlitz C, Oertli D, Maecke HR, Muller-Brand J, Walter MA. Iten F, et al. Among authors: schindler c. Cancer. 2009 May 15;115(10):2052-62. doi: 10.1002/cncr.24272. Cancer. 2009. PMID: 19280592 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,024 results

Search Page

Filters